What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 5 minute read Pharma Industry News Will pharmacokinetics data support 240 cm2 treatment fields for Ameluz? Biofrontera Inc. advances Ameluz toward 240 cm2 FDA review. Explore the regulatory, financial, and competitive stakes in dermatology markets. bySoujanya RaviFebruary 20, 2026